(Q51278552)

2 April 2018

title

Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C. (English)

1 reference

2 April 2018

1 reference

1

1 reference

2 April 2018

author name string

P Halfon

2

1 reference

2 April 2018

I Goldiner

3

1 reference

2 April 2018

S Zelber-Sagi

4

1 reference

2 April 2018

Z Halpern

5

1 reference

2 April 2018

R Oren

6

1 reference

2 April 2018

R Bruck

7

1 reference

2 April 2018

publication date

3 August 2012

1 reference

2 April 2018

Journal of Viral Hepatitis

published in

1 reference

2 April 2018

volume

20

1 reference

2 April 2018

issue

2

1 reference

2 April 2018

page(s)

95-102

1 reference

2 April 2018

Hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Enzymatic Fluorometry for Estimating Serum Total Bile Acid Concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Bile Acids Promote the Expression of Hepatitis C Virus in Replicon-Harboring Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Bile acids promote HCV replication through the EGFR/ERK pathway in replicon-harboring cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Assessment of fibrosis in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

Serum fibrosis markers: death by validation or a leap of faith?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01628.X

10.1111/J.1365-2893.2012.01628.X

21 January 2018

Identifiers

DOI

1 reference

2 April 2018

PubMed ID

23301544

1 reference

2 April 2018